| Lastest Insider Transactions Of CytomX Therapeutics, Inc. ( CTMX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | Chief Financial Officer | 2026-06-15 | Sell | 1,624 | 3.05 | 4,953 | 2026-06-17 18:38:53 |
| CTMX | CytomX Therapeutics, Inc. | Chu Yu-Waye | Chief Medical Officer | 2026-03-17 | Sell | 21,279 | 6.42 | 136,675 | 2026-03-19 18:41:25 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2026-03-17 | Sell | 118,969 | 6.42 | 764,138 | 2026-03-19 18:35:34 |
| CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, Chief Scientific Officer | 2026-03-17 | Sell | 31,492 | 6.42 | 202,273 | 2026-03-19 18:25:33 |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | Chief Financial Officer | 2026-03-17 | Sell | 19,323 | 6.42 | 124,112 | 2026-03-19 18:21:13 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2025-11-06 | Sell | 101,793 | 4.54 | 461,906 | 2025-11-10 16:05:32 |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | Chief Financial Officer | 2025-06-13 | Sell | 12,255 | 2.72 | 33,381 | 2025-06-17 16:11:18 |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | Chief Financial Officer | 2025-06-13 | Option Exercise | 37,500 | 0.00 | 0 | 2025-06-17 16:11:18 |
| CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, Chief Scientific Officer | 2025-06-13 | Sell | 13,884 | 2.69 | 37,334 | 2025-06-17 16:10:00 |
| CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, Chief Scientific Officer | 2025-06-13 | Option Exercise | 37,500 | 0.00 | 0 | 2025-06-17 16:10:00 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2025-06-13 | Sell | 55,511 | 2.69 | 149,264 | 2025-06-17 16:09:02 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2025-06-13 | Option Exercise | 150,000 | 0.00 | 0 | 2025-06-17 16:09:02 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2025-03-18 | Sell | 37,656 | 0.60 | 22,556 | 2025-03-20 16:34:40 |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | Chief Financial Officer | 2025-03-18 | Sell | 8,551 | 0.60 | 5,122 | 2025-03-20 16:33:49 |
| CTMX | CytomX Therapeutics, Inc. | Chu Yu-Waye | Chief Medical Officer | 2025-03-18 | Sell | 4,025 | 0.60 | 2,411 | 2025-03-20 16:32:56 |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | 2025-03-18 | Sell | 10,203 | 0.60 | 6,112 | 2025-03-20 16:32:22 |
| CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, Chief Scientific Officer | 2025-03-18 | Sell | 19,512 | 0.60 | 11,688 | 2025-03-20 16:31:34 |
| CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, Chief Scientific Officer | 2024-08-20 | Sell | 4,181 | 1.23 | 5,139 | 2024-08-22 18:01:09 |
| CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, Chief Scientific Officer | 2024-08-20 | Option Exercise | 11,250 | 0.00 | 0 | 2024-08-22 18:01:09 |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | Chief Financial Officer | 2024-08-20 | Sell | 1,984 | 1.23 | 2,439 | 2024-08-22 17:59:48 |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | Chief Financial Officer | 2024-08-20 | Option Exercise | 6,875 | 0.00 | 0 | 2024-08-22 17:59:48 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2024-08-20 | Sell | 13,898 | 1.23 | 17,082 | 2024-08-22 17:58:38 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2024-08-20 | Option Exercise | 37,500 | 0.00 | 0 | 2024-08-22 17:58:38 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2024-03-26 | Option Exercise | 109,768 | 1.57 | 172,874 | 2024-03-28 19:12:49 |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | 2024-03-19 | Sell | 5,268 | 2.09 | 10,986 | 2024-03-21 16:41:27 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2024-03-19 | Sell | 20,223 | 2.09 | 42,175 | 2024-03-21 16:40:09 |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | SVP, Finance and Accounting | 2024-03-19 | Sell | 2,971 | 2.09 | 6,196 | 2024-03-21 16:38:57 |
| CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, Chief Scientific Officer | 2024-03-19 | Sell | 12,795 | 2.09 | 26,684 | 2024-03-21 16:37:36 |
| CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Officer | 2024-03-19 | Sell | 6,562 | 2.09 | 13,685 | 2024-03-21 16:36:46 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2023-12-20 | Sell | 13,551 | 1.38 | 18,710 | 2023-12-22 16:16:04 |
| CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Officer | 2023-12-20 | Sell | 4,077 | 1.38 | 5,628 | 2023-12-22 16:12:57 |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | 2023-12-20 | Sell | 4,077 | 1.38 | 5,629 | 2023-12-22 16:11:46 |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | SVP, Finance and Accounting | 2023-12-20 | Sell | 1,990 | 1.38 | 2,747 | 2023-12-22 16:10:48 |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | SVP, Finance and Accounting | 2023-12-17 | Option Exercise | 6,875 | 0.00 | 0 | 2023-12-19 19:58:44 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2023-12-17 | Option Exercise | 37,500 | 0.00 | 0 | 2023-12-19 19:57:37 |
| CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Officer | 2023-12-17 | Option Exercise | 11,250 | 0.00 | 0 | 2023-12-19 19:56:09 |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | 2023-12-17 | Option Exercise | 11,250 | 0.00 | 0 | 2023-12-19 19:55:19 |
| CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, Chief Scientific Officer | 2023-12-17 | Option Exercise | 11,250 | 0.00 | 0 | 2023-12-19 19:54:36 |
| CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, Chief Scientific Officer | 2023-09-20 | Sell | 4,119 | 1.30 | 5,356 | 2023-09-22 19:16:52 |
| CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Business Officer | 2023-09-20 | Sell | 4,119 | 1.30 | 5,356 | 2023-09-22 19:15:12 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2023-09-20 | Sell | 14,601 | 1.30 | 18,987 | 2023-09-22 19:13:47 |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | 2023-09-20 | Sell | 5,486 | 1.30 | 7,135 | 2023-09-22 19:12:50 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2023-05-19 | Option Exercise | 16,535 | 1.57 | 26,041 | 2023-05-23 16:52:51 |
| CTMX | CytomX Therapeutics, Inc. | Jones Elaine V | Directior | 2023-03-29 | Buy | 5,000 | 1.55 | 7,750 | 2023-03-31 19:56:04 |
| CTMX | CytomX Therapeutics, Inc. | Ogden Christopher | SVP, Finance and Accounting | 2023-03-16 | Sell | 516 | 1.98 | 1,021 | 2023-03-20 18:43:35 |
| CTMX | CytomX Therapeutics, Inc. | Campoy Carlos | Chief Financial Officer | 2023-03-16 | Sell | 1,748 | 1.98 | 3,459 | 2023-03-20 18:43:33 |
| CTMX | CytomX Therapeutics, Inc. | McCarthy Sean A. | CEO | 2023-03-16 | Sell | 7,121 | 1.88 | 13,391 | 2023-03-20 18:43:33 |
| CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | General Counsel | 2023-03-16 | Sell | 2,037 | 1.98 | 4,031 | 2023-03-20 18:43:32 |
| CTMX | CytomX Therapeutics, Inc. | Landau Jeffrey B | Chief Financial Officer | 2023-03-16 | Sell | 1,477 | 1.98 | 2,923 | 2023-03-20 18:43:29 |
| CTMX | CytomX Therapeutics, Inc. | Peterson Amy C. | EVP, Chief Development Officer | 2023-03-16 | Sell | 4,257 | 1.98 | 8,425 | 2023-03-20 18:43:26 |
